Both in Lab Analytical Instruments
Pacific Biosciences of California vs Nautilus Biotechnolgy
Over the past year PACB returned +11.3% and NAUT returned +105.3%; their daily moves had a correlation of 0.21.
PACB +11.3% NAUT +105.3%Growth of $1, one year, split-adjusted
| Metric | PACB | NAUT |
|---|---|---|
| Price | $2.61 | $2.73 |
| Market cap | $809.7M | $347.7M |
| Today | −10.17% | −13.06% |
| 1 month | +3.8% | +73.9% |
| 6 months | +62.8% | +1.1% |
| Year to date | +39.3% | +40.0% |
| 1 year | +29.6% | +93.6% |
| Revenue growth (YoY) | −1.9% | — |
| Gross margin | 32.4% | 89.7% |
| Net margin | −114.7% | −6682.1% |
| P/E (TTM) | — | — |
| Price / sales | 5.1× | 820.1× |
| Net cash | -$407.5M | $86.6M |
| Dividend yield | — | — |
| Volatility (60d) | 114.2% | 152.3% |
| Short % of float | 18.2% | 10.4% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).